All COVID-19 Essential Drugs available in India: Check list

New Delhi, May 19: Amid cry over medicine shortage, the centre on Wednesday assured that the Government is monitoring supply of each COVID-19 Essential Drug.

"All drugs used in the management of COVID-19 are now available in India by ramping up production and increasing the imports. The availability of these drugs is being monitored by implementing three-pronged strategy of Supply Chain Management, Demand Side Management and Affordability," Minister of State Mansukh Mandaviya said.

Protocol Drugs:

Remdesivir
Enoxaparin
MethylPrednisolone
Dexamethasone
Tocilizumab
Ivermectin
Non-protocol Drugs:

Favipiravir
Amphotericin
Apixaban

CDSCO and NPPA are coordinating with manufacturers to enhance production and getting data about current stock, current capacities, Projected production for the May, 2021.

Remdesivir: Number of plants producing Remdesivir increased from 20 to 60 resulting in 3 times more availability in just 25 days. Production ramped up 10 times, from 10 lakhs vials/month in April'21 to ~1 crore/ month in May'21.

Toscilizumab injection: It is made available in the country by importing 20 times more than what was being done in normal times.

Dexamethasone 0.5 mg tablets production enhanced from 6-8 times within a month. Dexamethasone Injection production ramped up almost 2 times.

Enoxaparin Injection production increased 4 times in mere one month.

Methyl Prednisolone Injection: Production increased almost 3 times in a months time.

Ivermectin 12 mg tab production enhanced in the country by ~5 times within a month from 150 lakhs in April to 770 lakhs in May,2021.

Favirpiravir:
A non-protocol drug but it is used to lower the virus load .
The production increased 4 times within a month
From 326.5 lakh in April, 21 to 1644 lakh in May,21.

Amphoterecin B Injection:
Production ramped up ~ 3 times in a month.
3.80 lakh vials are in production and
3 lakh vials are being imported
Total 6.80 lakh vials will be available in the country.